REZUROCK Trademark

Trademark Overview


On Friday, July 24, 2020, a trademark application was filed for REZUROCK with the United States Patent and Trademark Office. The USPTO has given the REZUROCK trademark a serial number of 90071349. The federal status of this trademark filing is REGISTERED as of Tuesday, November 2, 2021. This trademark is owned by Kadmon Pharmaceuticals, LLC. The REZUROCK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical products for the prevention and treatment of respiratory diseases
rezurock

General Information


Serial Number90071349
Word MarkREZUROCK
Filing DateFriday, July 24, 2020
Status700 - REGISTERED
Status DateTuesday, November 2, 2021
Registration Number6548713
Registration DateTuesday, November 2, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements


Description of MarkThe mark consists of the wording "REZUROCK" having two arcs above the wording.
Goods and ServicesPharmaceuticals and pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical products for the prevention and treatment of respiratory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateTuesday, August 17, 2021
First Use In Commerce DateTuesday, August 17, 2021

Trademark Owner History


Party NameKadmon Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086

Party NameKadmon Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086

Party NameKadmon Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarrendale, PA 15086

Trademark Events


Event DateEvent Description
Tuesday, November 2, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, September 29, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 28, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, September 13, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 2, 2021USE AMENDMENT FILED
Monday, September 13, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 2, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, August 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 9, 2021SOU EXTENSION 1 GRANTED
Monday, August 9, 2021SOU EXTENSION 1 FILED
Monday, August 9, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 10, 2020ASSIGNED TO EXAMINER
Saturday, August 22, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 28, 2020NEW APPLICATION ENTERED